Literature DB >> 26032721

Cattle rabies vaccination--A longitudinal study of rabies antibody titres in an Israeli dairy herd.

Boris Yakobson1, Nick Taylor2, Nelli Dveres1, Shira Rozenblut1, Boris Even Tov1, Majid Markos1, Nadav Gallon1, David Homer3, Joanne Maki4.   

Abstract

In contrast to many regions of the world where rabies is endemic in terrestrial wildlife species, wildlife rabies has been controlled in Israel by oral rabies vaccination programs, but canine rabies is re-emerging in the northern area of the Golan Heights. From 2009 to 2014 there were 208 animal rabies cases in Israel; 96 (46%) were considered introduced primary cases in dogs, triggering 112 secondary cases. One third (37/112) of the secondary cases were in cattle. Rabies vaccination is voluntary for cattle in Israel, except those on public exhibit. Rabies vaccination schedules for cattle vary based on farm practices and perception of risk. In this study 59 cattle from a dairy farm which routinely vaccinates against rabies were assigned into six groups according to age and vaccination histories. Four groups contained adult cows which had received one previous rabies vaccination, one group of adults had received two previous vaccinations, and one group was unvaccinated calves. Serum samples were collected and the cows were vaccinated with a commercial rabies vaccine. Sera were again collected 39 days later and the calf group re-vaccinated and re-sampled 18 days later. Sera were analyzed for the presence of rabies virus neutralizing antibodies using the rapid immunofluorescent antibody test. Cattle with antibody titres ≥ 0.5 IU/ml were considered to be protected against rabies. Twenty-six of 27 adult cattle (96%) vaccinated once at less than five months old did not have protective titres. Sixty percent (6/10) cattle vaccinated once at around six months of age did have adequate titres. Cattle previously vaccinated twice (n=10; 100%) with an 18 month interval between inoculations, had protective titres and protective antibody titres following booster vaccination (n=51; 100%). The anamnestic response of cattle to a killed rabies vaccine was not affected by the time interval between vaccinations, which ranged from 12 to 36 months. These results suggest that calves from vaccinated cows should not be vaccinated before six months old to avoid maternal antibody interference. Whilst most cattle older than six months old will be protected after a single inoculation, a second inoculation ensures a higher antibody levels for improved protection. Cattle receiving an effective priming dose responded well to a booster up to 36 months later. Such results demonstrate the effectiveness of rabies vaccination in cattle and the added value of a second dose to ensure a prolonged immune response against rabies.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cattle; Protective antibodies; Rabies; Ruminant; Serology; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 26032721     DOI: 10.1016/j.prevetmed.2015.05.004

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  3 in total

1.  A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein.

Authors:  Caiquan Zhao; Jie Gao; Yongzhi Wang; Lina Ji; Hui Qin; Wei Hu; Yang Yang
Journal:  Front Microbiol       Date:  2022-06-08       Impact factor: 6.064

2.  Rabies Outbreaks and Vaccination in Domestic Camels and Cattle in Northwest China.

Authors:  Ye Liu; He-Ping Zhang; Shou-Feng Zhang; Jin-Xiang Wang; Hai-Ning Zhou; Fei Zhang; Yu-Mei Wang; Long Ma; Nan Li; Rong-Liang Hu
Journal:  PLoS Negl Trop Dis       Date:  2016-09-01

3.  Short Term Safety, Immunogenicity, and Reproductive Effects of Combined Vaccination With Anti-GnRH (Gonacon) and Rabies Vaccines in Female Feral Cats.

Authors:  Shiri Novak; Boris Yakobson; Shir Sorek; Liat Morgan; Smadar Tal; Ran Nivy; Roni King; Lauren Jaebker; Douglas C Eckery; Tal Raz
Journal:  Front Vet Sci       Date:  2021-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.